Cormorant Asset Management

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

Cormorant Asset Management is a Boston-based investment manager with investment focus in both public and private market innovative companies in the biotechnology and life sciences marketplace.

See All Exits Recent Exits

Phone:

Fax:



Boston,
Massachusetts, United States

Cormorant Asset Management - Investments & Acquisitions

Show Real Data Cormorant Asset Management Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-10-19TP TherapeuticsMezzanine$80MForesite Capital, HBM Healthcare Investments, Lilly Asia Ventures, Nextech Invest, OrbiMed Advisors, SR One, and venBIO
2018-09-12AtrecaSeries C$125MAisling Capital, Boxer Capital, EcoR1 Capital, Redmile Group, Samsara BioCapital, Tekla Capital Management, and Wellington Management
2018-09-05PhaseBio PharmaceuticalsSeries D$34MAstraZeneca, Fletcher Spaght Ventures, Hatteras Venture Partners, Johnson & Johnson Innovation, Mountain Group Capital, New Enterprise Associates, Rock Springs Capital, and Syno Capital
2018-08-13Orchard TherapeuticsSeries C$150MAgent Capital, ArrowMark Partners, Baillie Gifford & Co., Cowen Group, Deerfield Management, Driehaus Capital Management, Foresite Capital, Ghost Tree Capital Group, Medison Ventures, Perceptive Advisors, RA Capital Management, RTW Investments, Sphera Global Healthcare, Temasek Holdings, and Venrock
2018-07-24RenoviaSeries B$32.3MAscension Ventures, ATON Partners, Inova Strategic Investments, Longwood Fund, OSF Ventures, Perceptive Advisors, and Western Technology Investment
See all 5 investments